E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Mark S. Link,Robert P. Giugliano,Christian T. Ruff,Benjamin M. Scirica,Heikke Huikuri,Ali Oto,Andrea E. Crompton,Sabina A. Murphy,Hans Lanz,Hans Lanz,Michele Mercuri,Michele Mercuri,Elliott M. Antman,Eugene Braunwald +13 more
TL;DR: Patients with paroxysmal AF suffered fewer thromboembolic events and deaths compared with those with persistent and permanent AF, and the efficacy and safety profile of edoxaban as compared with warfarin was consistent across the 3 patterns of AF.
Journal ArticleDOI
Clinical Efficacy of Three Assays for Cardiac Troponin I for Risk Stratification in Acute Coronary Syndromes: A Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy
David A. Morrow,Nader Rifai,Milenko J. Tanasijevic,Donald R. Wybenga,James A. de Lemos,Elliott M. Antman +5 more
TL;DR: This study demonstrates the prognostic efficacy of three independently developed cTnI assays at a threshold of 0.1 microg/L for the prediction of adverse clinical outcomes among patients with non-ST-elevation acute coronary syndromes.
Journal ArticleDOI
Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non–ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature
Anthony A Bavry,Anthony A Bavry,Dharam J. Kumbhani,Rene Quiroz,Suneil R Ramchandani,Satish Kenchaiah,Satish Kenchaiah,Satish Kenchaiah,Elliott M. Antman +8 more
TL;DR: Routine invasive therapy in UA/NSTEMI patients along with adjunctive use of glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival.
Scientific Statement From the American Heart Association Use of Nonsteroidal Antiinflammatory Drugs : An Update for Clinicians: A
Kathryn A. Taubert,Elliott M. Antman,Joel S. Bennett,Alan Daugherty,Curt D. Furberg,Harold Roberts +5 more
Journal ArticleDOI
Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Report From the American Heart Association's Mission: Lifeline
James G. Jollis,Christopher B. Granger,Timothy D. Henry,Elliott M. Antman,Peter B. Berger,Peter Moyer,Franklin D Pratt,Ivan C. Rokos,Anna R. Acuña,Mayme L. Roettig,Alice K. Jacobs +10 more
TL;DR: This survey broadly describes the organizational characteristics of collaborative efforts by hospitals and emergency medical services to provide timely reperfusion in the United States and should help guide healthcare teams in the process of organizing care for patients with STEMI.